BrightSpring Health (BTSG) Fundamental Analysis: Revenue, Earnings & Valuation

7.48 / 10

Outperform

Fundamental analysis scores 7.48/10, highlighting exceptional YoY growth in cash flow per share, basic and diluted EPS, and total profit. Cash‑flow and earnings factors receive top weights, while Revenue‑MV and Net‑income‑Revenue lag, limiting upside but overall solid.

Analysis Checks(5/10)

Revenue-MV

Value1.62

Score1/3

Weight5.57%

1M Return2.00%

Net cash flow from operating activities per share (YoY growth rate %)

Value1769.93

Score3/3

Weight16.27%

1M Return5.07%

Inventory turnover ratio

Value15.70

Score1/3

Weight4.89%

1M Return1.74%

Net income-Revenue

Value-1.52

Score0/3

Weight-5.89%

1M Return-2.25%

Basic earnings per share (YoY growth rate %)

Value1144.44

Score3/3

Weight20.74%

1M Return6.64%

Total profit (YoY growth rate %)

Value244.72

Score3/3

Weight18.29%

1M Return5.90%

Net cash flow from operating activities (YoY growth rate %)

Value1961.79

Score3/3

Weight17.90%

1M Return5.49%

Cash-UP

Value0.57

Score1/3

Weight2.17%

1M Return0.84%

Diluted earnings per share (YoY growth rate %)

Value1066.67

Score3/3

Weight21.31%

1M Return6.86%

Cash-MV

Value0.35

Score1/3

Weight-1.24%

1M Return-0.45%

Is BTSG undervalued or overvalued?

BTSG scores 7.48/10 on fundamentals and holds a Discounted valuation at present. Backed by its 10.78% ROE, 1.46% net margin, 45.50 P/E ratio, 4.60 P/B ratio, and 1144.44% earnings growth, these metrics solidify its Outperform investment rating.